Giesel, Frederik L.
Heussel, Claus Peter
Lindner, Thomas
Röhrich, Manuel
Rathke, Hendrik
Kauczor, Hans-Ulrich
Debus, Jürgen
Haberkorn, Uwe
Kratochwil, Clemens http://orcid.org/0000-0003-1334-8260
Article History
Received: 19 February 2019
Accepted: 29 April 2019
First Online: 22 May 2019
Compliance with ethical standards
:
: The radiopharmaceutical was used on an individual patient basis according to German Pharmaceuticals Act §13(2b). The patient gave written informed consent to receive the novel diagnostics and permitted anonymized publication of related medical data. The ethical committee of Heidelberg University approved this retrospective evaluation to be in accordance with the Helsinki declaration (permit S016/2018). For case reports from clinical practice no trial registration is required.
: Giesel FL, Lindner T, Haberkorn U, Kratochwil C have a patent application for quinolone-based radiolabeled FAPI-ligands. The other authors have no conflict of interest to declare.